Based on these observations, we hypothesize that recombinant human (rh) ADAMTS13 might mitigate diabetes-induced retinal injury by improving endothelial dysfunction and inhibiting inflammation. The gene discussed is ADAMTS13; the disease is diabetes mellitus.